Sept 28 (Reuters) – Innovent Biologics, Inc.: * JAYPIRCA (PIRTROBRUTINIB) APPROVED IN CHINA FOR CLL/SLL ACROSS ALL LINES OF THERAPY Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
( ) MOSCOW, Sept 28 (Reuters) - Russian wheat export prices declined in line with…
VIDEO SHOWS: BELGIUM AND FRANCE FOOTBALL TEAMS TRAINING AHEAD OF UEFA NATIONS MATCH/ SOUNDBITES FROM…
By Mike Dolan Sept 28 (Reuters) - Nervy bond markets face another test this week…
Sept 28 (Reuters) - AI agent firm Instinct said on Monday it has raised $1…
MADRID, Sept 28 (Reuters) - Spain's representative in its North African enclave of Ceuta resigned…
VIDEO SHOWS: BELGIUM AND FRANCE FOOTBALL TEAMS TRAINING AHEAD OF UEFA NATIONS MATCH/ SOUNDBITES FROM…